Risultati per: FDA approva una pillola contro la depressione a effetto rapido

New England Journal of Medicine, Ahead of Print.

Farmaco regolatore orexina ruolo chiave anche in psicopatologia

This Special Communication examines advances in the use of artificial intelligence in health care and biomedicine and how regulatory entities like the US Food and Drug Administration must evaluate how artificial intelligence operates within these sectors to develop appropriate regulatory frameworks.

The US Food and Drug Administration (FDA) is considering removal of oral phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter (OTC) cold medications—including DayQuil, Theraflu, and Sudafed—after an extensive review of available data determined a lack of efficacy.

Colpiscono 1,5 miliardi di persone. Per l’Oms è un problema di salute pubblica

Pareggia su cifra 361 milioni euro, 6 milioni per investimenti

Nella settimana prima delle feste si sono aggiunti quasi 600mila pazienti, numeri in crescita ma inferiori alla stagione record dell’anno scorso

This Medical News article is an interview with FDA Commissioner Robert Califf, MD, about the agency’s regulatory powers over artificial intelligence tools for use in health care and biomedicine.

This Viewpoint discusses new pathways for researchers to seek collaboration when conducting studies on treatments for rare diseases and conditions.

The US Food and Drug Administration (FDA) recently approved a new treatment to prevent or reduce the frequency of bleeding episodes in patients 12 years or older with hemophilia A or hemophilia B. Whereas traditional hemophilia therapies use products that replace or mimic defective coagulation factors, marstacimab-hncq works by targeting a protein involved in blood clotting.

C’è una inversione anche tra i medici obiettori, fenomeno che rende complicato l’aborto in alcune Regioni e ospedali, che calano di numero.

The US Food and Drug Administration (FDA) recently granted authorization to market the first at-home influenza and COVID-19 combination test outside of emergency use.

Tre orfani, 7 nuovi e 6 estensioni delle indicazioni terapeutiche

Un decalogo della Sip per benessere dell’asse intestino-cervello

Un decalogo della Sip per benessere dell’asse intestino-cervello